Related Experiment Video
Updated: Feb 28, 2026

26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
18.9K
Acute Disseminated Encephalomyelitis (ADEM): Current View into Etiopathogenesis and Clinical Features
Klara Ferenc1, Piotr Semik1, Justyna Paprocka1
1Pediatric Neurology Department, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland.
Brain Sciences
|February 27, 2026
Summary
Acute disseminated encephalomyelitis (ADEM) is a rare immune disorder affecting the central nervous system. Understanding its triggers and immune mechanisms is crucial for improving diagnosis and management of this challenging condition.
Area of Science:
- Neuroimmunology
- Neurology
- Demyelinating Diseases
Background:
- Acute disseminated encephalomyelitis (ADEM) is a rare immune-mediated demyelinating disorder of the central nervous system (CNS).
- Its etiopathogenesis remains poorly understood, often triggered by infections or immunizations.
- Diagnosis is challenging due to lack of specific biomarkers and overlap with other demyelinating syndromes.
Purpose of the Study:
- To review current knowledge on ADEM's etiopathogenesis and clinical characteristics.
- To highlight recent research implications for clinical practice and disease management.
- To discuss diagnostic challenges and heterogeneity of ADEM.
Main Methods:
- This is a narrative review.
- It synthesizes current literature on ADEM.
- Emphasis is placed on immunopathogenesis and clinical/radiological features.
Main Results:
- Post-infectious immune mechanisms like molecular mimicry and BBB disruption are key.
- Diverse triggers include infections, vaccinations, and genetic factors.
- Clinical and neuroimaging features can aid differentiation, but diagnostic limitations persist.
Conclusions:
- ADEM pathogenesis is complex, involving immune dysregulation leading to CNS demyelination.
- Recent advances in immunopathogenesis offer insights into diagnosis and management.
- Recognizing ADEM's heterogeneity is vital for effective clinical approaches.
Keywords:
ADEMacute disseminated encephalomyelitisimmune-mediated demyelinationmolecular mimicryneuroinflammationpediatric neurologyMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Endocarditis II: Clinical Features of Infective Endocarditis
634
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
634
Toxidromes: Clinical Features
47
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
47

